These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2198049)

  • 1. Methods of assessing the effect of drug therapy on quality of life.
    Ganz PA
    Drug Saf; 1990; 5(4):233-42. PubMed ID: 2198049
    [No Abstract]   [Full Text] [Related]  

  • 2. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.
    Bombardier C; Ware J; Russell IJ; Larson M; Chalmers A; Read JL
    Am J Med; 1986 Oct; 81(4):565-78. PubMed ID: 3532786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost effectiveness of auranofin: results of a randomized clinical trial.
    Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED
    J Rheumatol; 1988 Jan; 15(1):35-42. PubMed ID: 3127585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auranofin and quality of life.
    Morgan GJ
    Scand J Rheumatol; 1988; 17(5):363. PubMed ID: 3212406
    [No Abstract]   [Full Text] [Related]  

  • 5. Measuring costs and financial benefits in randomized controlled trials.
    Bulpitt CJ; Fletcher AE
    Am Heart J; 1990 Mar; 119(3 Pt 2):766-70; discussion 770-1. PubMed ID: 2106770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.
    Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L
    J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients receiving auranofin therapy: confirmation of efficacy using nontraditional health status measures.
    Morgan GJ
    Scand J Rheumatol Suppl; 1986; 63():29-35. PubMed ID: 3299681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auranofin (SK&F) in early rheumatoid arthritis: results from a 24-month double-blind, placebo-controlled study. Effect on clinical and biochemical assessments.
    Johnsen V; Borg G; Trang LE; Berg E; Brodin U
    Scand J Rheumatol; 1989; 18(5):251-60. PubMed ID: 2688083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open trial of auranofin (oral gold preparation) in rheumatoid arthritis.
    Malaviya AN; Kabra KR; Kumar A
    J Assoc Physicians India; 1986 Sep; 34(9):625-7. PubMed ID: 3539909
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis].
    Atakhodzhaeva ZA; Sigidin IaA
    Ter Arkh; 1987; 59(12):30-3. PubMed ID: 3328906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Auranofin in the treatment of rheumatoid arthritis: a multicenter double-blind prospective clinical trial].
    Yang JL
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):486-8. PubMed ID: 8275829
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol.
    Fletcher AE; Bulpitt CJ; Hawkins CM; Havinga TK; ten Berge BS; May JF; Schuurman FH; van der Veur E; Wesseling H
    J Hypertens; 1990 May; 8(5):463-6. PubMed ID: 2163421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study.
    Harth M; Davis P; Thompson JM; Menard H; Beaudet F
    Scand J Rheumatol; 1987; 16(3):177-84. PubMed ID: 3110944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of captopril in rheumatoid arthritis: combining treatment targets!
    Popa CD; van Riel PL
    Can J Cardiol; 2013 May; 29(5):639.e13. PubMed ID: 23541661
    [No Abstract]   [Full Text] [Related]  

  • 15. Auranofin versus placebo in rheumatoid arthritis.
    Suarez-Almazor ME; Spooner CH; Belseck E; Shea B
    Cochrane Database Syst Rev; 2000; 2000(2):CD002048. PubMed ID: 10796461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin: a new drug for rheumatoid arthritis.
    Ann Intern Med; 1987 Apr; 106(4):631-2. PubMed ID: 3826966
    [No Abstract]   [Full Text] [Related]  

  • 17. Auranofin in rheumatoid arthritis: what variables could affect the clinical response?
    Harth M
    Agents Actions Suppl; 1988; 24():167-77. PubMed ID: 3055876
    [No Abstract]   [Full Text] [Related]  

  • 18. [Captopril and rheumatoid arthritis].
    la Cour Petersen E
    Ugeskr Laeger; 1987 Oct; 149(43):2921. PubMed ID: 3324425
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of health-related quality-of-life measures for rheumatoid arthritis research. The Auranofin Cooperating Group.
    Bombardier C; Raboud J
    Control Clin Trials; 1991 Aug; 12(4 Suppl):243S-256S. PubMed ID: 1663860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of auranofin and sulphasalazine therapy on circulating levels of interleukin 6 in rheumatoid arthritis patients.
    Crilly A; Capell HA; Watson J; Madhok R
    Clin Rheumatol; 1995 Sep; 14(5):561-5. PubMed ID: 8549096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.